FDA Provides New PDUFA Date for Sumavel DosePro

Zogenix, Inc., a private, specialty pharmaceutical company, announced that the U.S. Food & Drug Administration has provided a target date of July 15, 2009 for completion of its review of the NDA for Sumavel DosePro (sumatriptan injection) needle-free delivery system.
The Earth Times